• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Nutrien Reports Fourth Quarter and Full-Year 2024 Results

    2/19/25 5:24:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email
    • Full-year results demonstrate significant progress towards strategic priorities and 2026 performance targets.
    • 2025 guidance reflects expectation for continued growth in upstream fertilizer volumes, higher downstream Retail earnings and lower capital expenditures.

    All amounts are in US dollars, except as otherwise noted

    Nutrien Ltd. (TSX and NYSE:NTR) announced today its fourth quarter 2024 results, with net earnings of $118 million ($0.23 diluted net earnings per share). Fourth quarter 2024 adjusted EBITDA1 was $1.1 billion and adjusted net earnings per share1 was $0.31.

    "Nutrien delivered higher upstream fertilizer sales volumes, accelerated operational efficiency and cost savings initiatives and increased downstream Retail earnings in 2024, demonstrating significant progress towards our 2026 performance targets. We took a disciplined and intentional approach to our capital allocation decisions, further optimizing capital expenditures and returning $1.2 billion to shareholders through dividends and share repurchases," commented Ken Seitz, Nutrien's President and CEO.

    "The outlook for our business in 2025 is supported by expectations for strong crop input demand and firming potash fundamentals. Nutrien has a world-class asset base, and we remain focused on strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow," added Mr. Seitz.

    Highlights2:

    • Generated net earnings of $700 million ($1.36 diluted net earnings per share) and adjusted EBITDA of $5.4 billion ($3.47 adjusted net earnings per share) for the full year of 2024.
    • Retail adjusted EBITDA increased to $1.7 billion in 2024 supported by higher product margins and lower expenses, as we continue to simplify our business and accelerate downstream network optimization initiatives.
    • Potash adjusted EBITDA decreased to $1.8 billion in 2024 as lower net selling prices more than offset increased sales volumes. We mined 35 percent of our potash ore tonnes using automation in 2024, providing efficiency, flexibility and safety benefits, while supporting our highest annual production levels on record and a reduction in controllable cash cost of product manufactured per tonne.
    • Nitrogen adjusted EBITDA of $1.9 billion in 2024 was relatively flat as lower net selling prices offset higher sales volumes and lower natural gas costs. Total ammonia production increased in 2024, driven by less maintenance downtime and improved natural gas utilization and reliability at our operations in Trinidad.
    • Divested non-core assets and equity investments totaling approximately $60 million in 2024, providing incremental cash flow to allocate to high conviction priorities that are core to our long-term strategy.
    • Repurchased 3.9 million shares for a total of $190 million in the second half of 2024 and an additional 1.9 million shares in 2025 for $96 million as of February 18, 2025. Nutrien's Board of Directors approved the purchase of up to 5 percent of Nutrien's outstanding common shares over a twelve-month period through the renewal of our normal course issuer bid ("NCIB"), which is subject to acceptance by the Toronto Stock Exchange.
    • Nutrien's Board of Directors approved an increase in the quarterly dividend to $0.545 per share. Nutrien continues to target a stable and growing dividend, having now increased the dividend per share by 36 percent since the beginning of 2018.
    1.

    This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2.

    Our discussion of highlights set out on this page is a comparison of the results for the twelve months ended December 31, 2024 to the results for the twelve months ended December 31, 2023, unless otherwise noted.

     
     

    Market Outlook and Guidance

    Agriculture and Retail Markets

    • Global grain stocks-to-use ratios remain historically low and demand remains strong, providing a supportive environment for ag commodity prices in 2025. We expect US corn plantings to range between 91 and 93 million acres and soybean plantings to range from 84 to 86 million acres in 2025. The projected increase in corn acreage, combined with a shortened fall application season in 2024, supports our outlook for strong North American fertilizer demand in the first half of the year.
    • In Brazil, generally favorable soil moisture conditions and stronger crop prices are expected to lead to an increase in safrinha corn planted acreage of approximately five percent, supporting crop input demand in the first half of 2025.
    • A weaker Australian dollar and strong grain and oilseed export demand is supporting grower economics, and conditions remain positive for 2025 crop input demand.

    Crop Nutrient Markets

    • Global potash shipments rebounded to approximately 72.5 million tonnes in 2024, driven by improved supply and supportive application economics that contributed to increased demand in key markets such as China, Brazil and Southeast Asia.
    • We forecast global potash shipments between 71 and 75 million tonnes in 2025. The high end of the range captures the potential for stronger underlying global consumption and the lower end captures the potential for reduced supply availability. We anticipate the potential for supply tightness with limited global capacity additions in 2025 and reported operational challenges and maintenance work in key producing regions.
    • Global urea and UAN prices have increased in the first quarter of 2025, driven by strengthening demand in key import markets and restricted supply, including continued Chinese urea export restrictions. Global ammonia prices have trended lower to start the year due to seasonal demand weakness and the anticipation of incremental supply in the US and export capacity from Russia. We expect North American natural gas prices to remain highly competitive compared to Europe and Asia, with Henry Hub natural gas prices projected to average between $3.25 and $3.50 per MMBtu for the year.
    • The US nitrogen supply and demand balance is expected to be tight ahead of the spring application season, as nitrogen fertilizer net imports in the first half of the 2024/2025 fertilizer year were down approximately 60 percent compared to the five-year average. Additionally, nitrogen demand for the spring season is expected to be strong due to the limited fall ammonia application season and higher projected corn acreage.
    • Phosphate fertilizer markets remain firm, particularly in North America where inventories were estimated to be historically low entering 2025. We expect Chinese phosphate exports similar to 2024 levels, with total DAP/MAP exports ranging between 6 and 7 million tonnes, and tight stocks in India to support demand ahead of their key planting season.

    Financial and Operational Guidance

    • Retail adjusted EBITDA guidance of $1.65 to $1.85 billion assumes higher crop nutrient sales volumes, continued growth of our proprietary products and further margin recovery in Brazil. We anticipate foreign exchange headwinds in our international retail operations and the absence of asset sales and other income items realized in 2024, which combined are estimated at approximately $75 million.
    • Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with our global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability.
    • Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at our North American plants.
    • Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at our White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.
    • Total capital expenditures of $2.0 to $2.1 billion are expected to be lower than the prior year. Our capital expenditure program has been further optimized to sustain safe and reliable operations and to progress a set of targeted growth investments. This total includes approximately $400 to $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions in Nitrogen and mine automation projects in Potash.

    All guidance numbers, including those noted above, are outlined in the table below. In addition, set forth below are anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

     

    2025 Guidance Ranges 1 as of

    February 19, 2025

     

     

     

    (billions of US dollars, except as otherwise noted)

    Low

     

    High

     

    2024 Actual

     

    Retail adjusted EBITDA

    1.65

     

    1.85

     

    1.7

     

    Potash sales volumes (million tonnes) 2

    13.6

     

    14.4

     

    13.9

     

    Nitrogen sales volumes (million tonnes) 2

    10.7

     

    11.2

     

    10.7

     

    Phosphate sales volumes (million tonnes) 2

    2.35

     

    2.55

     

    2.4

     

    Depreciation and amortization

    2.35

     

    2.45

     

    2.3

     

    Finance costs

    0.65

     

    0.75

     

    0.7

     

    Effective tax rate on adjusted net earnings (%) 3

    22.0

     

    25.0

     

    24.1

    Capital expenditures 4

    2.0

     

    2.1

     

     2.2

     

    1 See the "Forward-Looking Statements" section.

     

    2 Manufactured product only.

     

    3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     

    4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

     

     

     

     

     

    2025 Annual Sensitivities 1

    Effect on

    (millions of US dollars, except EPS amounts)

    Adjusted EBITDA

    Adjusted EPS 4

    $25 per tonne change in potash net selling prices

     ± 280

     

     ± 0.45

    $25 per tonne change in ammonia net selling prices 2

     ±   35

     

     ± 0.05

    $25 per tonne change in urea and ESN® net selling prices

     ±   85

     

     ± 0.15

    $25 per tonne change in solutions, nitrates and sulfates net selling prices

     ± 130

     

     ± 0.20

    $1 per MMBtu change in NYMEX natural gas price 3

     ± 190

     

    ± 0.30

    1 See the "Forward-Looking Statements" section.

    2 Includes related impact on natural gas costs in Trinidad, which is linked to benchmark ammonia pricing.

    3 Nitrogen related impact.

    4 Assumes 486 million shares outstanding for all earnings per share ("EPS") sensitivities.

     

    Consolidated Results

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

    Sales

    5,079

     

    5,664

     

    (10)

     

    25,972

     

    29,056

     

    (11)

    Gross margin

    1,581

     

    1,768

     

    (11)

     

    7,530

     

    8,474

     

    (11)

    Expenses

    1,184

     

    1,475

     

    (20)

     

    5,674

     

    5,729

     

    (1)

    Net earnings

    118

     

    176

     

    (33)

     

    700

     

    1,282

     

    (45)

    Adjusted EBITDA 1

    1,055

     

    1,075

     

    (2)

     

    5,355

     

    6,058

     

    (12)

    Diluted net earnings per share (US dollars)

    0.23

     

    0.35

     

    (34)

     

    1.36

     

    2.53

     

    (46)

    Adjusted net earnings per share (US dollars) 1

    0.31

     

    0.37

     

    (16)

     

    3.47

     

    4.44

     

    (22)

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     

    Net earnings and adjusted EBITDA decreased in the fourth quarter of 2024 compared to the same period in 2023, primarily due to lower Potash net selling prices and sales volumes, partially offset by higher Retail earnings and lower expenses. For the full year of 2024, net earnings and adjusted EBITDA decreased compared to 2023 due to lower Potash and Nitrogen net selling prices, partially offset by increased Retail earnings and record Potash sales volumes. Net earnings were also impacted by a previously disclosed loss on foreign currency derivatives in the second quarter of 2024.



    Segment Results

    Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2024 to the results for the three and twelve months ended December 31, 2023, unless otherwise noted.

    Nutrien Ag Solutions ("Retail")

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

    Sales

    3,179

     

    3,502

     

    (9)

     

    17,832

     

    19,542

     

    (9)

    Cost of goods sold

    2,193

     

    2,513

     

    (13)

     

    13,211

     

    15,112

     

    (13)

    Gross margin

    986

     

    989

     

    ‐

     

    4,621

     

    4,430

     

    4

    Adjusted EBITDA 1

    340

     

    229

     

    48

     

    1,696

     

    1,459

     

    16

    1 See Note 2 to the unaudited condensed consolidated financial statements as at and for the three and twelve months ended December 31, 2024 ("interim financial statements").

    • Retail adjusted EBITDA increased in the fourth quarter of 2024 due to lower expenses and higher crop protection and seed margins, including increased proprietary products gross margins and improved margins and selling expenses in Brazil. During the fourth quarter, we recognized a $25 million gain on the sale of land in Argentina as we continue to simplify our business. Adjusted EBITDA increased for the full year, supported by higher product margins in all geographies and lower expenses.
     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Sales

     

    Gross Margin

     

    Sales

     

    Gross Margin

    (millions of US dollars)

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

    Crop nutrients

    1,528

     

    1,808

     

    294

     

    346

     

    7,211

     

    8,379

     

    1,444

     

    1,378

    Crop protection products

    948

     

    960

     

    351

     

    333

     

    6,313

     

    6,750

     

    1,622

     

    1,553

    Seed

    184

     

    202

     

    52

     

    36

     

    2,235

     

    2,295

     

    431

     

    427

    Services and other

    228

     

    236

     

    188

     

    188

     

    918

     

    927

     

    716

     

    710

    Merchandise

    230

     

    251

     

    40

     

    41

     

    897

     

    1,001

     

    150

     

    172

    Nutrien Financial

    77

     

    70

     

    77

     

    70

     

    361

     

    322

     

    361

     

    322

    Nutrien Financial elimination 1

    (16)

     

    (25)

     

    (16)

     

    (25)

     

    (103)

     

    (132)

     

    (103)

     

    (132)

    Total

    3,179

     

    3,502

     

    986

     

    989

     

    17,832

     

    19,542

     

    4,621

     

    4,430

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    • Crop nutrients sales decreased in the fourth quarter of 2024 due to lower sales volumes, which were impacted by wet weather in North America and strategic actions related to our margin improvement plan in Brazil. Full-year 2024 sales were impacted by lower selling prices and sales volumes. Gross margin decreased in the fourth quarter as higher per-tonne margins in North America were more than offset by lower sales volumes. For the full year, gross margin increased due to higher per-tonne margins in North America, including growth in our proprietary crop nutritional and biostimulant product lines.
    • Crop protection products sales were lower in the fourth quarter and full year of 2024 mainly due to lower selling prices. Gross margin improvements for the fourth quarter and full year of 2024 were supported by proprietary products, strong operational execution and the selling through of lower cost inventory in South America compared to the same periods in 2023.
    • Seed sales decreased in the fourth quarter and full year of 2024 mainly due to the impact of competitive pricing pressure in South America. Gross margin for the fourth quarter increased, supported by higher proprietary gross margin, including improved margins in South America due to strategic actions related to our margin improvement plan in Brazil. Full-year 2024 gross margin increased as improved margins in North America more than offset the impact of dry weather and competitive market pressures in Brazil.
    • Merchandise sales and gross margin decreased in the fourth quarter and full year of 2024 due to reductions in Australia primarily related to weather-related impacts on water equipment sales and animal health products.
    • Nutrien Financial sales and gross margin increased in the fourth quarter and full year of 2024 due to higher financing rates offered.
     

    Supplemental Data

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Gross Margin

     

    % of Product Line 1

     

    Gross Margin

     

    % of Product Line 1

    (millions of US dollars, except

    as otherwise noted)

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

    Proprietary products

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Crop nutrients

    60

     

    44

     

    19

     

    12

     

    421

     

    391

     

    29

     

    28

    Crop protection products

    41

     

    27

     

    11

     

    10

     

    470

     

    461

     

    29

     

    30

    Seed

    6

     

    (3)

     

    16

     

    (9)

     

    154

     

    168

     

    36

     

    39

    Merchandise

    4

     

    3

     

    9

     

    6

     

    15

     

    11

     

    10

     

    6

    Total

    111

     

    71

     

    11

     

    8

     

    1,060

     

    1,031

     

    23

     

    23

    1 Represents percentage of proprietary product margins over total product line gross margin.

     
     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (US dollars)

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (US dollars)

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

    Crop nutrients

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    North America

    1,854

     

    2,073

     

    125

     

    118

     

    8,547

     

    8,985

     

    142

     

    127

    International

    716

     

    790

     

    87

     

    127

     

    3,715

     

    3,647

     

    62

     

    65

    Total

    2,570

     

    2,863

     

    114

     

    120

     

    12,262

     

    12,632

     

    118

     

    109

     
     

    (percentages)

    December 31, 2024

     

    December 31, 2023

    Financial performance measures 1, 2

     

     

     

    Cash operating coverage ratio

    63

     

    68

    Adjusted average working capital to sales

    20

     

    19

    Adjusted average working capital to sales excluding Nutrien Financial

    ‐

     

    1

    Nutrien Financial adjusted net interest margin

    5.3

     

    5.2

    1 Rolling four quarters.

    2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

    Potash

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

    % Change

     

    2024

     

    2023

    % Change

    Net sales

    536

     

    776

     

    (31)

     

    2,989

     

    3,759

     

    (20)

    Cost of goods sold

    309

     

    349

     

    (11)

     

    1,448

     

    1,396

     

    4

    Gross margin

    227

     

    427

     

    (47)

     

    1,541

     

    2,363

     

    (35)

    Adjusted EBITDA 1

    291

     

    463

     

    (37)

     

    1,848

     

    2,404

     

    (23)

    1 See Note 2 to the interim financial statements.

    • Potash adjusted EBITDA decreased in the fourth quarter of 2024 due to lower net selling prices and sales volumes. Full-year 2024 adjusted EBITDA was lower mainly due to lower net selling prices, partially offset by record sales volumes. Higher potash production supported by the continued advancement of mine automation contributed to our lower controllable cash cost of product manufactured for the full year of 2024.
     

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ / tonne, except as otherwise noted)

    2024

     

    2023

     

    2024

     

    2023

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    North America

    718

     

    1,089

     

    4,672

     

    4,843

    Offshore

    2,040

     

    2,214

     

    9,214

     

    8,373

    Total sales volumes

    2,758

     

    3,303

     

    13,886

     

    13,216

    Net selling price

     

     

     

     

     

     

     

    North America

    270

     

    342

     

    285

     

    348

    Offshore

    168

     

    182

     

    180

     

    248

    Average net selling price

    194

     

    235

     

    215

     

    284

    Cost of goods sold

    112

     

    106

     

    104

     

    105

    Gross margin

    82

     

    129

     

    111

     

    179

    Depreciation and amortization

    49

     

    36

     

    44

     

    35

    Gross margin excluding depreciation and amortization 1

    131

     

    165

     

    155

     

    214

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes decreased in the fourth quarter of 2024 compared to the record volumes delivered in the same period in the prior year due to a more restricted fall application window in North America and lower volumes to China and Other Asian markets. Full-year 2024 sales volumes were the highest on record, supported by low channel inventories and strong potash affordability in North America and key offshore markets.
    • Net selling price per tonne decreased in the fourth quarter and full year of 2024 primarily due to a decline in benchmark prices compared to the same periods in 2023.
    • Cost of goods sold per tonne increased in the fourth quarter of 2024 as higher depreciation and the impact of more planned turnaround activity more than offset lower royalties. For the full year, cost of goods sold per tonne decreased primarily due to higher production volumes and lower royalties, partially offset by higher depreciation.

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2024

     

    2023

     

    2024

     

    2023

    Production volumes (tonnes – thousands)

    3,369

     

    3,386

     

    14,205

     

    12,998

    Potash controllable cash cost of product manufactured

    per tonne 1

    59

     

    56

     

    54

     

    58

    Canpotex sales by market (percentage of sales volumes)

     

     

     

     

     

     

     

    Latin America

    35

     

    32

     

    40

     

    47

    Other Asian markets 2

    24

     

    28

     

    28

     

    28

    China

    16

     

    19

     

    13

     

    9

    India

    11

     

    11

     

    7

     

    5

    Other markets

    14

     

    10

     

    12

     

    11

    Total

    100

     

    100

     

    100

     

    100

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 All Asian markets except China and India.

    Nitrogen

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

    % Change

     

    2024

     

    2023

    % Change

    Net sales

    1,013

     

    956

     

    6

     

    3,745

     

    4,207

     

    (11)

    Cost of goods sold

    700

     

    671

     

    4

     

    2,535

     

    2,828

     

    (10)

    Gross margin

    313

     

    285

     

    10

     

    1,210

     

    1,379

     

    (12)

    Adjusted EBITDA 1

    471

     

    391

     

    20

     

    1,884

     

    1,930

     

    (2)

    1 See Note 2 to the interim financial statements.

     
    • Nitrogen adjusted EBITDA increased in the fourth quarter of 2024 primarily due to higher sales volumes and ammonia net selling prices. Adjusted EBITDA for the full year was relatively flat as lower net selling prices offset higher sales volumes and lower natural gas costs. Our total ammonia production increased in the fourth quarter and full year supported by less maintenance downtime and improved natural gas utilization and reliability at our operations in Trinidad.

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ / tonne, except as otherwise noted)

    2024

     

    2023

     

    2024

     

    2023

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Ammonia

    701

     

    651

     

    2,483

     

    2,436

    Urea and ESN®

    888

     

    739

     

    3,188

     

    3,125

    Solutions, nitrates and sulfates

    1,325

     

    1,344

     

    5,023

     

    4,862

    Total sales volumes

    2,914

     

    2,734

     

    10,694

     

    10,423

    Net selling price

     

     

     

     

     

     

     

    Ammonia

    448

     

    416

     

    410

     

    469

    Urea and ESN®

    403

     

    428

     

    421

     

    480

    Solutions, nitrates and sulfates

    213

     

    215

     

    221

     

    244

    Average net selling price

    327

     

    321

     

    324

     

    367

    Cost of goods sold

    221

     

    218

     

    213

     

    233

    Gross margin

    106

     

    103

     

    111

     

    134

    Depreciation and amortization

    58

     

    53

     

    55

     

    55

    Gross margin excluding depreciation and amortization 1

    164

     

    156

     

    166

     

    189

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes increased in the fourth quarter due to higher urea production and strong regional demand for ammonia. Full-year 2024 sales volumes increased due to higher production at our operations in Trinidad and reliability improvements across our network in North America increasing the availability of upgraded products.
    • Net selling price per tonne was higher in the fourth quarter of 2024 primarily due to stronger ammonia net selling prices and a favorable geographic mix. For the full year, net selling price per tonne was lower for all major nitrogen products due to weaker benchmark prices.
    • Cost of goods sold per tonne increased in the fourth quarter of 2024 mainly due to higher natural gas costs in Trinidad, partially offset by lower natural gas costs in North America. For the full year, cost of goods sold per tonne decreased primarily due to lower natural gas costs in North America and the impact of higher production volumes.

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2024

     

    2023

     

    2024

     

    2023

    Sales volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Fertilizer

    1,801

     

    1,648

     

    6,259

     

    6,067

    Industrial and feed

    1,113

     

    1,086

     

    4,435

     

    4,356

    Production volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Ammonia production – total 1

    1,451

     

    1,362

     

    5,608

     

    5,357

    Ammonia production – adjusted 1, 2

    1,041

     

    1,022

     

    3,953

     

    3,902

    Ammonia operating rate (%) 2

    92

     

    91

     

    88

     

    88

    Natural gas costs (US dollars per MMBtu)

     

     

     

     

     

     

     

    Overall natural gas cost excluding realized derivative impact

    3.61

     

    3.35

     

    3.15

     

    3.51

    Realized derivative impact 3

    0.10

     

    (0.05)

     

    0.09

     

    (0.02)

    Overall natural gas cost

    3.71

     

    3.30

     

    3.24

     

    3.49

    1 All figures are provided on a gross production basis in thousands of product tonnes.

    2 Excludes Trinidad and Joffre.

    3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 4 to the interim financial statements.

    Phosphate

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

    % Change

     

    2024

     

    2023

    % Change

    Net sales

    414

     

    533

     

    (22)

     

    1,657

     

    1,993

     

    (17)

    Cost of goods sold

    394

     

    463

     

    (15)

     

    1,510

     

    1,760

     

    (14)

    Gross margin

    20

     

    70

     

    (71)

     

    147

     

    233

     

    (37)

    Adjusted EBITDA 1

    86

     

    130

     

    (34)

     

    384

     

    470

     

    (18)

    1 See Note 2 to the interim financial statements.

    • Phosphate adjusted EBITDA was lower in the fourth quarter of 2024 as higher net selling prices were more than offset by the impact of lower production volumes and higher input costs. Adjusted EBITDA for the full year decreased due to weaker industrial and feed net selling prices and the impact of lower production, partially offset by lower sulfur and ammonia input costs.
     

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ / tonne, except as otherwise noted)

    2024

     

    2023

     

    2024

     

    2023

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Fertilizer

    435

     

    579

     

    1,751

     

    1,912

    Industrial and feed

    173

     

    174

     

    683

     

    639

    Total sales volumes

    608

     

    753

     

    2,434

     

    2,551

    Net selling price

     

     

     

     

     

     

     

    Fertilizer

    615

     

    557

     

    612

     

    568

    Industrial and feed

    812

     

    860

     

    822

     

    1,010

    Average net selling price

    671

     

    627

     

    671

     

    678

    Cost of goods sold

    631

     

    535

     

    603

     

    583

    Gross margin

    40

     

    92

     

    68

     

    95

    Depreciation and amortization

    127

     

    108

     

    119

     

    115

    Gross margin excluding depreciation and amortization 1

    167

     

    200

     

    187

     

    210

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes were lower in the fourth quarter and full year primarily due to weather-related events and plant outages that impacted production volumes.
    • Net selling price per tonne increased in the fourth quarter of 2024 primarily due to the strength of fertilizer benchmark prices. For the full year of 2024, net selling price per tonne decreased due to lower industrial and feed net selling prices which reflect the typical lag in price realizations relative to benchmark prices.
    • Cost of goods sold per tonne increased in the fourth quarter of 2024 due to lower production volumes, higher depreciation, and higher input costs, including sulfur. Full-year cost of goods sold per tonne increased due to lower production volumes and higher water treatment costs related to weather-related events, partially offset by lower sulfur and ammonia input costs.
     

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2024

     

    2023

     

    2024

     

    2023

    Production volumes (P2O5 tonnes – thousands)

    319

     

    380

     

    1,327

     

    1,406

    P2O5 operating rate (%)

    75

     

    89

     

    78

     

    83

     

    Corporate and Others and Eliminations

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

    Corporate and Others

     

     

     

     

     

     

     

     

     

     

     

    Gross margin 1

    13

     

    ‐

     

    n/m

     

    13

     

    ‐

     

    n/m

    Selling expenses

    7

     

    7

     

    ‐

     

    ‐

     

    ‐

     

    ‐

    General and administrative expenses

    126

     

    104

     

    21

     

    403

     

    364

     

    11

    Share-based compensation expense (recovery)

    20

     

    (7)

     

    n/m

     

    37

     

    (14)

     

    n/m

    Foreign exchange loss (income), net of related derivatives

    1

     

    (14)

     

    n/m

     

    360

     

    91

     

    296

    Other expenses

    105

     

    175

     

    (40)

     

    379

     

    257

     

    47

    Adjusted EBITDA 1

    (160)

     

    (117)

     

    37

     

    (456)

     

    (267)

     

    71

    Eliminations

     

     

     

     

     

     

     

     

     

     

     

    Gross margin

    22

     

    (3)

     

    n/m

     

    (2)

     

    69

     

    n/m

    Adjusted EBITDA 1

    27

     

    (21)

     

    n/m

     

    (1)

     

    62

     

    n/m

    1 See Note 2 to the interim financial statements.

    • Share-based compensation was an expense in the fourth quarter and full year of 2024 due to an increase in the fair value of our share-based awards. We had a recovery in the same periods in 2023 as the fair value of our share-based awards decreased. The fair value of our share-based awards takes into consideration several factors such as our share price movement, our performance relative to our peer group and our return on invested capital.
    • Foreign exchange loss, net of related derivatives was higher in the full year of 2024 compared to the same period in 2023 as it included a previously disclosed $220 million loss on foreign currency derivatives in Brazil.
    • Other expenses were lower in the fourth quarter of 2024 compared to the same period in 2023 mainly due to a lower expense for asset retirement obligations and accrued environmental costs related to our non-operating sites partially offset by higher restructuring costs. Other expenses in the full year of 2024 were higher compared to the same period in 2023 due to an $80 million gain in the full year of 2023 from our other post-retirement benefit plan amendments. These were partially offset by lower losses related to our financial instruments in Argentina. Refer to Note 4 of the interim financial statements for additional information.
    • Eliminations of gross margin in the full year of 2024 resulted from higher intersegment inventory held by our Retail segment compared to a recovery of gross margin in the full year of 2023, which reflected the sell-through of higher cost inventory.





    Finance Costs, Income Taxes and Other Comprehensive Income (Loss)

     

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

    Finance costs

    195

     

    213

     

    (8)

     

    720

     

    793

     

    (9)

    Income taxes

     

     

     

     

     

     

     

     

     

     

     

    Income tax expense (recovery)

    84

     

    (96)

     

    n/m

     

    436

     

    670

     

    (35)

    Actual effective tax rate including discrete items (%)

    42

     

    (120)

     

    n/m

     

    38

     

    34

     

    12

    Other comprehensive (loss) income

    (298)

     

    97

     

    n/m

     

    (234)

     

    81

     

    n/m

    • Finance costs were lower in the fourth quarter and full year of 2024 primarily due to lower average short-term debt balance from lower working capital requirements, partially offset by the increase in average long-term debt balance throughout 2024.
    • Income tax was an expense in the fourth quarter of 2024 compared to a recovery in the same period in 2023 mainly due to higher earnings and lower discrete tax adjustments. In the fourth quarter of 2023, our discrete tax items included a $134 million income tax recovery due to changes in our tax declarations in Switzerland ("Swiss Tax Reform"). These factors resulted in a positive effective tax rate in the fourth quarter of 2024 compared to a negative effective tax rate in the same period in 2023.



      The lower income tax expense in the full year of 2024 compared to the same period in 2023 was due to lower earnings and lower discrete tax adjustments. The discrete tax adjustments in the same period in 2023 were related to a change in recognition of deferred tax assets in South America as they no longer met the asset recognition criteria, the impact of the Swiss Tax Reform, and Canadian audit assessments.
    • Other comprehensive loss in the fourth quarter and full year of 2024 was mainly due to the depreciation of the Australian, Brazilian and Canadian currencies, relative to the US dollar, compared to gains for the same periods in 2023.





    Forward-Looking Statements

    Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to:

    Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2025 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; our 2026 performance targets; expectations regarding our capital allocation intentions and strategies, including our target of providing a stable and growing dividend; our ability to advance strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow; capital spending expectations for 2025 and beyond, including the expectation that related investments will sustain safe and reliable operations and drive growth; expectations regarding performance of our operating segments in 2025 and beyond; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders.

    These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

    All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

    The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies on the anticipated timeline or at all; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets and normalization of Canpotex port operations; global economic conditions and the accuracy of our market outlook expectations for 2025 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets, including in relation to our Retail - Brazil business asset impairments; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

    Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets, such as our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, including the imposition of any tariffs, or other changes to international trade arrangements; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

    The purpose of our revised Retail adjusted EBITDA and our depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

    The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.





    Terms and Definitions

    For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2023 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.





    About Nutrien

    Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

    More information about Nutrien can be found at www.nutrien.com.

    Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool

    Such data is not incorporated by reference herein.

    Nutrien will host a Conference Call on Thursday, February 20, 2025 at 10:00 a.m. Eastern Time.

    Telephone conference dial-in numbers:

    • From Canada and the US: 1 (800) 206-4400
    • International: 1 (289) 514-5005
    • No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

    Live Audio Webcast: Visit https://www.nutrien.com/news/events/2024-q4-earnings-conference-call





    Non-GAAP Financial Measures

    We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

    These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

    The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

    Adjusted EBITDA (Consolidated)

    Most directly comparable IFRS financial measure: Net earnings (loss).

    Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

    Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

     

     

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    (millions of US dollars)

    2024

     

    2023

     

    2024

     

    2023

    Net earnings

    118

     

    176

     

    700

     

    1,282

    Finance costs

    195

     

    213

     

    720

     

    793

    Income tax expense (recovery)

    84

     

    (96)

     

    436

     

    670

    Depreciation and amortization

    590

     

    565

     

    2,339

     

    2,169

    EBITDA 1

    987

     

    858

     

    4,195

     

    4,914

    Adjustments:

     

     

     

     

     

     

     

    Share-based compensation expense (recovery)

    20

     

    (7)

     

    37

     

    (14)

    Foreign exchange loss (gain), net of related

    derivatives

    1

     

    (14)

     

    360

     

    91

    ARO/ERL related (income) expenses for

    non-operating sites

    (1)

     

    142

     

    151

     

    152

    Loss related to financial instruments in Argentina

    1

     

    ‐

     

    35

     

    92

    Restructuring costs

    47

     

    20

     

    47

     

    49

    Impairment of assets

    ‐

     

    76

     

    530

     

    774

    Adjusted EBITDA

    1,055

     

    1,075

     

    5,355

     

    6,058

    1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

    Adjusted Net Earnings and Adjusted Net Earnings Per Share

    Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

    Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

     

    Three Months Ended

    December 31, 2024

    Twelve Months Ended

    December 31, 2024

     

     

     

     

    Per

     

     

     

    Per

    (millions of US dollars, except as otherwise

    Increases

     

     

    Diluted

    Increases

     

     

    Diluted

    noted)

    (Decreases)

     

    Post-Tax

    Share

    (Decreases)

     

    Post-Tax

    Share

    Net earnings attributable to equity holders

    of Nutrien

     

     

    113

    0.23

     

     

    674

    1.36

    Adjustments:

     

     

     

     

     

     

     

     

    Share-based compensation expense

    20

     

    15

    0.03

    37

     

    27

    0.05

    Foreign exchange (gain) loss, net of related

    derivatives

    1

     

    (16)

    (0.03)

    360

     

    346

    0.70

    Restructuring costs

    47

     

    38

    0.08

    47

     

    38

    0.08

    Impairment of assets

    ‐

     

    ‐

    ‐

    530

     

    492

    1.00

    ARO/ERL related (income) expenses for

    non-operating sites

    (1)

     

    (1)

    ‐

    151

     

    106

    0.21

    Loss related to financial instruments in

    Argentina

    1

     

    1

    ‐

    35

     

    35

    0.07

    Sub-total adjustments

    68

    37

    0.08

    1,160

    1,044

    2.11

     

    Adjusted net earnings

     

     

    150

    0.31

     

     

    1,718

    3.47

     
     

     

    Three Months Ended

    December 31, 2023

    Twelve Months Ended

    December 31, 2023

     

     

     

     

    Per

     

     

     

    Per

    (millions of US dollars, except as otherwise

    Increases

     

     

    Diluted

    Increases

     

     

    Diluted

    noted)

    (Decreases)

     

    Post-Tax

    Share

    (Decreases)

     

    Post-Tax

    Share

    Net earnings attributable to equity holders

    of Nutrien

     

     

    172

    0.35

     

     

    1,258

    2.53

    Adjustments:

     

     

     

     

     

     

     

     

    Share-based compensation recovery

    (7)

     

    (5)

    (0.01)

    (14)

     

    (11)

    (0.02)

    Foreign exchange (gain) loss, net of related

    derivatives

    (14)

     

    (16)

    (0.03)

    91

     

    83

    0.17

    Restructuring costs

    20

     

    16

    0.03

    49

     

    40

    0.08

    Impairment of assets

    76

     

    49

    0.10

    774

     

    702

    1.42

    ARO/ERL related expenses for non-operating

    sites

    142

     

    102

    0.20

    152

     

    110

    0.22

    Loss related to financial instruments in

    Argentina

    ‐

     

    ‐

    ‐

    92

     

    92

    0.18

    Swiss Tax Reform adjustment

    (134)

     

    (134)

    (0.27)

    (134)

     

    (134)

    (0.27)

    Change in recognition of deferred tax assets

    ‐

     

    ‐

    ‐

    66

     

    66

    0.13

    Sub-total adjustments

    83

    12

    0.02

    1,076

    948

    1.91

     

    Adjusted net earnings

     

     

    184

    0.37

     

     

    2,206

    4.44

    Effective Tax Rate on Adjusted Net Earnings

    Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

    Effective tax rate on adjusted net earnings ratio is calculated as adjusted income tax expense divided by adjusted earnings before income taxes. We use this measure to provide the actual result for a previously disclosed forward-looking effective tax rate on adjusted net earnings guidance. 

    (millions of US dollars, except as otherwise noted)

     

     

     

     

     

     

     

     

     

     

    2024

     

    Earnings before income taxes

     

     

     

     

     

     

     

     

     

     

    1,136

     

    Adjustments 1

     

     

     

     

     

     

     

     

     

     

    1,160

     

    Adjusted earnings before income taxes

     

     

     

     

     

     

     

     

     

     

    2,296

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Income tax expense

     

     

     

     

     

     

     

     

     

     

    436

     

    Adjustments 2

     

     

     

     

     

     

     

     

     

     

    116

     

    Adjusted income tax expense

     

     

     

     

     

     

     

     

     

     

    552

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Effective tax rate on adjusted net earnings (%)

     

     

     

     

     

     

     

     

     

     

    24.1

     

    1  Calculated as sum of pre-tax adjustments noted in the Adjusted Net Earnings section.

     

    2  Calculated as difference between the sum of pre-tax and post-tax adjustments noted in the Adjusted Net Earnings section.

     

    Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

    Most directly comparable IFRS financial measure: Gross margin.

    Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

    Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

    Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

    Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

    Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

     

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

    2023

     

    2024

     

    2023

    Total COGS – Potash

    309

     

    349

     

    1,448

     

    1,396

    Change in inventory

    66

     

    7

     

    36

     

    (40)

    Other adjustments 1

    (7)

     

    (7)

     

    (21)

     

    (26)

    COPM

    368

     

    349

     

    1,463

     

    1,330

    Depreciation and amortization in COPM

    (142)

     

    (124)

     

    (581)

     

    (427)

    Royalties in COPM

    (17)

     

    (23)

     

    (79)

     

    (100)

    Natural gas costs and carbon taxes in COPM

    (9)

     

    (12)

     

    (36)

     

    (46)

    Controllable cash COPM

    200

     

    190

     

    767

     

    757

    Production tonnes (tonnes – thousands)

    3,369

     

    3,386

     

    14,205

     

    12,998

    Potash controllable cash COPM per tonne

    59

     

    56

     

    54

     

    58

    1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

    Nutrien Financial Adjusted Net Interest Margin

    Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

     

     

    Rolling four quarters ended December 31, 2024

    (millions of US dollars, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total/Average

    Nutrien Financial revenue

    66

     

    133

     

    85

     

    77

     

     

    Deemed interest expense 1

    (27)

     

    (50)

     

    (52)

     

    (45)

     

     

    Net interest

    39

     

    83

     

    33

     

    32

     

    187

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,489

     

    4,560

     

    4,318

     

    2,877

     

    3,561

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.3

     

     

     

     

     

     

     

     

     

     

     

    Rolling four quarters ended December 31, 2023

    (millions of US dollars, except as otherwise noted)

    Q1 2023

     

    Q2 2023

     

    Q3 2023

     

    Q4 2023

     

    Total/Average

    Nutrien Financial revenue

    57

     

    122

     

    73

     

    70

     

     

    Deemed interest expense 1

    (20)

     

    (39)

     

    (41)

     

    (36)

     

     

    Net interest

    37

     

    83

     

    32

     

    34

     

    186

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,283

     

    4,716

     

    4,353

     

    2,893

     

    3,561

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.2

    1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

    Retail Cash Operating Coverage Ratio

    Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

     

     

    Rolling four quarters ended December 31, 2024

    (millions of US dollars, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total

    Selling expenses

    790

     

    1,005

     

    815

     

    808

     

    3,418

    General and administrative expenses

    52

     

    51

     

    51

     

    37

     

    191

    Other expenses

    22

     

    41

     

    32

     

    (8)

     

    87

    Operating expenses

    864

     

    1,097

     

    898

     

    837

     

    3,696

    Depreciation and amortization in operating expenses

    (190)

     

    (193)

     

    (182)

     

    (186)

     

    (751)

    Operating expenses excluding depreciation and amortization

    674

     

    904

     

    716

     

    651

     

    2,945

     

     

     

     

     

     

     

     

     

     

    Gross margin

    747

     

    2,029

     

    859

     

    986

     

    4,621

    Depreciation and amortization in cost of goods sold

    4

     

    3

     

    8

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    751

     

    2,032

     

    867

     

    991

     

    4,641

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    63

     

     

     

     

     

     

     

     

     

     

     

    Rolling four quarters ended December 31, 2023

    (millions of US dollars, except as otherwise noted)

    Q1 2023

     

    Q2 2023

     

    Q3 2023

     

    Q4 2023

     

    Total

    Selling expenses

    765

     

    971

     

    798

     

    841

     

    3,375

    General and administrative expenses

    50

     

    55

     

    57

     

    55

     

    217

    Other expenses

    15

     

    29

     

    37

     

    77

     

    158

    Operating expenses

    830

     

    1,055

     

    892

     

    973

     

    3,750

    Depreciation and amortization in operating expenses

    (179)

     

    (185)

     

    (186)

     

    (199)

     

    (749)

    Operating expenses excluding depreciation and amortization

    651

     

    870

     

    706

     

    774

     

    3,001

     

     

     

     

     

     

     

     

     

     

    Gross margin

    615

     

    1,931

     

    895

     

    989

     

    4,430

    Depreciation and amortization in cost of goods sold

    2

     

    3

     

    3

     

    2

     

    10

    Gross margin excluding depreciation and amortization

    617

     

    1,934

     

    898

     

    991

     

    4,440

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    68

    Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

    Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

    Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

     

     

    Rolling four quarters ended December 31, 2024

    (millions of US dollars, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Average/Total

    Current assets

    11,821

     

    11,181

     

    10,559

     

    10,360

     

     

    Current liabilities

    (8,401)

     

    (8,002)

     

    (5,263)

     

    (8,028)

     

     

    Working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Nutrien Financial working capital

    (2,489)

     

    (4,560)

     

    (4,318)

     

    (2,877)

     

     

    Adjusted working capital excluding Nutrien Financial

    931

     

    (1,381)

     

    978

     

    (545)

     

    (4)

     

     

     

     

     

     

     

     

     

     

    Sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

    17,832

    Nutrien Financial revenue

    (66)

     

    (133)

     

    (85)

     

    (77)

     

     

    Adjusted sales excluding Nutrien Financial

    3,242

     

    7,941

     

    3,186

     

    3,102

     

    17,471

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    20

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    -

     

     

     

     

     

     

     

     

     

     

     

    Rolling four quarters ended December 31, 2023

    (millions of US dollars, except as otherwise noted)

    Q1 2023

     

    Q2 2023

     

    Q3 2023

     

    Q4 2023

     

    Average/Total

    Current assets

    13,000

     

    11,983

     

    10,398

     

    10,498

     

     

    Current liabilities

    (8,980)

     

    (8,246)

     

    (5,228)

     

    (8,210)

     

     

    Working capital

    4,020

     

    3,737

     

    5,170

     

    2,288

     

    3,804

    Working capital from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted working capital

    4,020

     

    3,737

     

    5,170

     

    2,288

     

    3,804

    Nutrien Financial working capital

    (2,283)

     

    (4,716)

     

    (4,353)

     

    (2,893)

     

     

    Adjusted working capital excluding Nutrien Financial

    1,737

     

    (979)

     

    817

     

    (605)

     

    243

     

     

     

     

     

     

     

     

     

     

    Sales

    3,422

     

    9,128

     

    3,490

     

    3,502

     

     

    Sales from certain recent acquisitions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

     

    Adjusted sales

    3,422

     

    9,128

     

    3,490

     

    3,502

     

    19,542

    Nutrien Financial revenue

    (57)

     

    (122)

     

    (73)

     

    (70)

     

     

    Adjusted sales excluding Nutrien Financial

    3,365

     

    9,006

     

    3,417

     

    3,432

     

    19,220

     

     

     

     

     

     

     

     

     

     

    Adjusted average working capital to sales (%)

     

     

     

     

     

     

     

     

    19

    Adjusted average working capital to sales excluding Nutrien Financial (%)

     

     

     

    1

     
     

    Other Financial Measures

    Selected Additional Financial Data

     

    Nutrien Financial

    As at December 31, 2024

    As at

    December 31, 2023

    (millions of US dollars)

    Current

    <31 Days

    Past Due

    31–90

    Days

    Past Due

    >90 Days

    Past Due

    Gross

    Receivables

    Allowance 1

    Net

    Receivables

    Net

    Receivables

    North America

    1,671

    289

    112

    156

    2,228

    (50)

    2,178

    2,206

    International

    575

    51

    19

    64

    709

    (10)

    699

    687

    Nutrien Financial receivables

    2,246

    340

    131

    220

    2,937

    (60)

    2,877

    2,893

    1 Bad debt expense on the above receivables for the twelve months ended December 31, 2024 and 2023 were $55 million and $35 million, respectively, in the Retail segment.

    Supplementary Financial Measures

    Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

    The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

    Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

    Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures excludes capital outlays for business acquisitions and equity-accounted investees.

    Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

    Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.





    Condensed Consolidated Financial Statements

    Unaudited

    Condensed Consolidated Statements of Earnings

     

     

     

    Three Months Ended

     

    Twelve Months Ended

     

     

    December 31

     

    December 31

    (millions of US dollars, except as otherwise noted)

    Note

    2024

     

    2023

     

    2024

     

    2023

    SALES

    2, 10

    5,079

     

    5,664

     

    25,972

     

    29,056

    Freight, transportation and distribution

     

    215

     

    260

     

    956

     

    974

    Cost of goods sold

     

    3,283

     

    3,636

     

    17,486

     

    19,608

    GROSS MARGIN

     

    1,581

     

    1,768

     

    7,530

     

    8,474

    Selling expenses

     

    813

     

    849

     

    3,435

     

    3,397

    General and administrative expenses

     

    176

     

    173

     

    644

     

    626

    Provincial mining taxes

     

    45

     

    79

     

    255

     

    398

    Share-based compensation expense (recovery)

     

    20

     

    (7)

     

    37

     

    (14)

    Impairment of assets

    3

    ‐

     

    76

     

    530

     

    774

    Foreign exchange loss (gain), net of related derivatives

    6

    1

     

    (14)

     

    360

     

    91

    Other expenses

    4

    129

     

    319

     

    413

     

    457

    EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

    397

     

    293

     

    1,856

     

    2,745

    Finance costs

     

    195

     

    213

     

    720

     

    793

    EARNINGS BEFORE INCOME TAXES

     

    202

     

    80

     

    1,136

     

    1,952

    Income tax expense (recovery)

    5

    84

     

    (96)

     

    436

     

    670

    NET EARNINGS

     

    118

     

    176

     

    700

     

    1,282

    Attributable to

     

     

     

     

     

     

     

     

    Equity holders of Nutrien

     

    113

     

    172

     

    674

     

    1,258

    Non-controlling interest

     

    5

     

    4

     

    26

     

    24

    NET EARNINGS

     

    118

     

    176

     

    700

     

    1,282

     

     

     

     

     

     

     

     

     

    NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN ("EPS")

    Basic

     

    0.23

     

    0.35

     

    1.36

     

    2.53

    Diluted

     

    0.23

     

    0.35

     

    1.36

     

    2.53

    Weighted average shares outstanding for basic EPS

     

    492,843,000

     

    494,545,000

     

    494,198,000

     

    496,381,000

    Weighted average shares outstanding for diluted EPS

     

    492,930,000

     

    494,878,000

     

    494,365,000

     

    496,994,000

     

     

     

     

     

     

     

     

     

    Condensed Consolidated Statements of Comprehensive (Loss) Income

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars, net of related income taxes)

    2024

     

    2023

     

    2024

     

    2023

    NET EARNINGS

    118

     

    176

     

    700

     

    1,282

    Other comprehensive (loss) income

     

     

     

     

     

     

     

    Items that will not be reclassified to net earnings:

     

     

     

     

     

     

     

    Net actuarial gain (loss) on defined benefit plans

    17

     

    (14)

     

    17

     

    (17)

    Net fair value gain (loss) on investments

    2

     

    (1)

     

    55

     

    4

    Items that have been or may be subsequently reclassified to net earnings:

     

     

     

     

     

     

     

    (Loss) gain on currency translation of foreign operations

    (282)

     

    103

     

    (254)

     

    89

    Other

    (35)

     

    9

     

    (52)

     

    5

    OTHER COMPREHENSIVE (LOSS) INCOME

    (298)

     

    97

     

    (234)

     

    81

    COMPREHENSIVE (LOSS) INCOME

    (180)

     

    273

     

    466

     

    1,363

    Attributable to

     

     

     

     

     

     

     

    Equity holders of Nutrien

    (182)

     

    268

     

    443

     

    1,338

    Non-controlling interest

    2

     

    5

     

    23

     

    25

    COMPREHENSIVE (LOSS) INCOME

    (180)

     

    273

     

    466

     

    1,363

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Cash Flows

     

     

     

    Three Months Ended

     

    Twelve Months Ended

     

     

    December 31

     

    December 31

    (millions of US dollars)

    Note

    2024

     

    2023

     

    2024

     

    2023

     

     

     

     

    Note 1

     

     

     

    Note 1

    OPERATING ACTIVITIES

     

     

     

     

     

     

     

     

    Net earnings

     

    118

     

    176

     

    700

     

    1,282

    Adjustments for:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    590

     

    565

     

    2,339

     

    2,169

    Share-based compensation expense (recovery)

     

    20

     

    (7)

     

    37

     

    (14)

    Impairment of assets

    3

    ‐

     

    76

     

    530

     

    774

    Provision for (recovery of) deferred income tax

     

    16

     

    (169)

     

    31

     

    7

    Net (undistributed) distributed earnings of equity-accounted investees

     

    (22)

     

    5

     

    (8)

     

    117

    Loss related to financial instruments in Argentina

    4

    1

     

    ‐

     

    35

     

    92

    Long-term income tax receivables and payables

     

    30

     

    24

     

    47

     

    (65)

    Other long-term assets, liabilities and miscellaneous

     

    (16)

     

    153

     

    311

     

    197

    Cash from operations before working capital changes

     

    737

     

    823

     

    4,022

     

    4,559

    Changes in non-cash operating working capital:

     

     

     

     

     

     

     

     

    Receivables

     

    2,170

     

    2,370

     

    (224)

     

    879

    Inventories and prepaid expenses and other current assets

     

    (2,205)

     

    (1,990)

     

    60

     

    1,376

    Payables and accrued charges

     

    2,421

     

    2,947

     

    (323)

     

    (1,748)

    CASH PROVIDED BY OPERATING ACTIVITIES

     

    3,123

     

    4,150

     

    3,535

     

    5,066

    INVESTING ACTIVITIES

     

     

     

     

     

     

     

     

    Capital expenditures 1

     

    (767)

     

    (760)

     

    (2,154)

     

    (2,600)

    Business acquisitions, net of cash acquired

     

    (15)

     

    (37)

     

    (21)

     

    (153)

    Proceeds from (purchase of) investments, held within three months, net

     

    74

     

    22

     

    44

     

    (112)

    Purchase of investments

     

    ‐

     

    (19)

     

    (112)

     

    (31)

    Net changes in non-cash working capital

     

    82

     

    46

     

    27

     

    (22)

    Other

     

    107

     

    15

     

    83

     

    (40)

    CASH USED IN INVESTING ACTIVITIES

     

    (519)

     

    (733)

     

    (2,133)

     

    (2,958)

    FINANCING ACTIVITIES

     

     

     

     

     

     

     

     

    Repayment of debt, maturing within three months, net

     

    (1,231)

     

    (2,671)

     

    (142)

     

    (458)

    Proceeds from debt

    8

    24

     

    ‐

     

    1,022

     

    1,500

    Repayment of debt

    8

    (527)

     

    (13)

     

    (659)

     

    (648)

    Repayment of principal portion of lease liabilities

     

    (102)

     

    (97)

     

    (402)

     

    (375)

    Dividends paid to Nutrien's shareholders

    9

    (265)

     

    (262)

     

    (1,060)

     

    (1,032)

    Repurchase of common shares, inclusive of related tax

    9

    (134)

     

    ‐

     

    (184)

     

    (1,047)

    Issuance of common shares

     

    2

     

    1

     

    18

     

    33

    Other

     

    (6)

     

    ‐

     

    (46)

     

    (34)

    CASH USED IN FINANCING ACTIVITIES

     

    (2,239)

     

    (3,042)

     

    (1,453)

     

    (2,061)

    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND

    CASH EQUIVALENTS

     

    (32)

     

    12

     

    (37)

     

    (7)

    INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     

    333

     

    387

     

    (88)

     

    40

    CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

     

    520

     

    554

     

    941

     

    901

    CASH AND CASH EQUIVALENTS – END OF PERIOD

     

    853

     

    941

     

    853

     

    941

    Cash and cash equivalents is composed of:

     

     

     

     

     

     

     

     

    Cash

     

    741

     

    909

     

    741

     

    909

    Short-term investments

     

    112

     

    32

     

    112

     

    32

     

     

    853

     

    941

     

    853

     

    941

    SUPPLEMENTAL CASH FLOWS INFORMATION

     

     

     

     

     

     

     

     

    Interest paid

     

    244

     

    267

     

    740

     

    729

    Income taxes paid

     

    61

     

    42

     

    321

     

    1,764

    Total cash outflow for leases

     

    140

     

    128

     

    558

     

    501

    1 Includes additions to property, plant and equipment, and intangible assets for the three months ended December 31, 2024 of $735 million and $32 million (2023 – $716 million and $44 million), respectively, and for the twelve months ended December 31, 2024 of $2,025 million and $129 million (2023 – $2,415 million and $185 million), respectively.

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Changes in Shareholders' Equity

     

     

     

     

     

     

     

    Accumulated Other Comprehensive

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (Loss) Income ("AOCI")

     

     

     

     

     

     

     

    (millions of US dollars, inclusive of related tax, except as otherwise noted)

    Number of

    Common

    Shares

     

    Share

    Capital

     

    Contributed

    Surplus

     

    (Loss) Gain

    on Currency

    Translation

    of Foreign

    Operations

     

    Other

     

    Total

    AOCI

     

    Retained

    Earnings

     

    Equity

    Holders

    of

    Nutrien

     

    Non-

    Controlling

    Interest

     

    Total

    Equity

    BALANCE – DECEMBER 31, 2022

    507,246,105

     

    14,172

     

    109

     

    (374)

     

    (17)

     

    (391)

     

    11,928

     

    25,818

     

    45

     

    25,863

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1,258

     

    1,258

     

    24

     

    1,282

    Other comprehensive income (loss)

    ‐

     

    ‐

     

    ‐

     

    88

     

    (8)

     

    80

     

    ‐

     

    80

     

    1

     

    81

    Shares repurchased (Note 9)

    (13,378,189)

     

    (374)

     

    (26)

     

    ‐

     

    ‐

     

    ‐

     

    (600)

     

    (1,000)

     

    ‐

     

    (1,000)

    Dividends declared - $2.12/share

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1,050)

     

    (1,050)

     

    ‐

     

    (1,050)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (2)

     

    (2)

     

    (25)

     

    (27)

    Effect of share-based compensation including

    issuance of common shares

    683,814

     

    40

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    40

     

    ‐

     

    40

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (14)

     

    (14)

     

    14

     

    ‐

     

    ‐

     

    ‐

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    12

     

    12

     

    ‐

     

    12

     

    ‐

     

    12

    Transfer of net actuarial loss on defined benefit plans

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    17

     

    17

     

    (17)

     

    ‐

     

    ‐

     

    ‐

    BALANCE – DECEMBER 31, 2023

    494,551,730

     

    13,838

     

    83

     

    (286)

     

    (10)

     

    (296)

     

    11,531

     

    25,156

     

    45

     

    25,201

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    674

     

    674

     

    26

     

    700

    Other comprehensive (loss) income

    ‐

     

    ‐

     

    ‐

     

    (251)

     

    20

     

    (231)

     

    ‐

     

    (231)

     

    (3)

     

    (234)

    Shares repurchased (Note 9)

    (3,944,903)

     

    (110)

     

    (20)

     

    ‐

     

    ‐

     

    ‐

     

    (60)

     

    (190)

     

    ‐

     

    (190)

    Dividends declared - $2.16/share

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1,063)

     

    (1,063)

     

    ‐

     

    (1,063)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (33)

     

    (33)

    Effect of share-based compensation including

    issuance of common shares

    418,619

     

    20

     

    5

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    25

     

    ‐

     

    25

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    7

     

    7

     

    ‐

     

    7

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    29

     

    29

     

    ‐

     

    29

     

    ‐

     

    29

    Transfer of net actuarial gain on defined benefit plans

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (17)

     

    (17)

     

    17

     

    ‐

     

    ‐

     

    ‐

    BALANCE – DECEMBER 31, 2024

    491,025,446

     

    13,748

     

    68

     

    (537)

     

    22

     

    (515)

     

    11,106

     

    24,407

     

    35

     

    24,442

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Balance Sheets

     

     

    December 31

     

    December 31

    As at (millions of US dollars)

    Note

    2024

     

    2023

    ASSETS

     

     

     

     

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    853

     

    941

    Receivables

    6, 7, 10

    5,390

     

    5,398

    Inventories

     

    6,148

     

    6,336

    Prepaid expenses and other current assets

     

    1,401

     

    1,495

     

     

    13,792

     

    14,170

    Non-current assets

     

     

     

     

    Property, plant and equipment

    3

    22,604

     

    22,461

    Goodwill

    3

    12,043

     

    12,114

    Intangible assets

    3

    1,819

     

    2,217

    Investments

     

    698

     

    736

    Other assets

     

    884

     

    1,051

    TOTAL ASSETS

     

    51,840

     

    52,749

    LIABILITIES

     

     

     

     

    Current liabilities

     

     

     

     

    Short-term debt

    7

    1,534

     

    1,815

    Current portion of long-term debt

    8

    1,037

     

    512

    Current portion of lease liabilities

     

    356

     

    327

    Payables and accrued charges

    6

    9,118

     

    9,467

     

     

    12,045

     

    12,121

    Non-current liabilities

     

     

     

     

    Long-term debt

    8

    8,881

     

    8,913

    Lease liabilities

     

    999

     

    999

    Deferred income tax liabilities

     

    3,539

     

    3,574

    Pension and other post-retirement benefit liabilities

     

    227

     

    252

    Asset retirement obligations and accrued environmental costs

     

    1,543

     

    1,489

    Other non-current liabilities

     

    164

     

    200

    TOTAL LIABILITIES

     

    27,398

     

    27,548

    SHAREHOLDERS' EQUITY

     

     

     

     

    Share capital

    9

    13,748

     

    13,838

    Contributed surplus

     

    68

     

    83

    Accumulated other comprehensive loss

     

    (515)

     

    (296)

    Retained earnings

     

    11,106

     

    11,531

    Equity holders of Nutrien

     

    24,407

     

    25,156

    Non-controlling interest

     

    35

     

    45

    TOTAL SHAREHOLDERS' EQUITY

     

    24,442

     

    25,201

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

     

    51,840

     

    52,749

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)





    Notes to the Condensed Consolidated Financial Statements

    As at and for the Three and Twelve Months Ended December 31, 2024

    Note 1 Basis of presentation

    Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

    These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements.

    Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of cash flows and Note 4 Other expenses.

    In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

    These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on February 19, 2025.

    Note 2 Segment information

    We have four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core business. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

    (millions of US dollars)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

     

    Assets – as at December 31, 2024

    22,149

     

    13,792

     

    11,603

     

    2,453

     

    2,571

     

    (728)

     

    51,840

     

    Assets – as at December 31, 2023

    23,056

     

    13,571

     

    11,466

     

    2,438

     

    2,818

     

    (600)

     

    52,749

     
     
       

     

     

    Three Months Ended December 31, 2024

     

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

    (millions of US dollars)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

     

    Sales

    – third party

    3,179

     

    522

     

    953

     

    403

     

    22

     

    ‐

     

    5,079

     

     

    – intersegment

    ‐

     

    65

     

    223

     

    68

     

    ‐

     

    (356)

     

    ‐

     

    Sales

    – total

    3,179

     

    587

     

    1,176

     

    471

     

    22

     

    (356)

     

    5,079

     

    Freight, transportation and

    distribution

    ‐

     

    51

     

    163

     

    57

     

    ‐

     

    (56)

     

    215

     

    Net sales

    3,179

     

    536

     

    1,013

     

    414

     

    22

     

    (300)

     

    4,864

     

    Cost of goods sold

    2,193

     

    309

     

    700

     

    394

     

    9

     

    (322)

     

    3,283

     

    Gross margin

    986

     

    227

     

    313

     

    20

     

    13

     

    22

     

    1,581

     

    Selling expenses (recovery)

    808

     

    1

     

    3

     

    1

     

    7

     

    (7)

     

    813

     

    General and administrative

    expenses

    37

     

    2

     

    8

     

    3

     

    126

     

    ‐

     

    176

     

    Provincial mining taxes

    ‐

     

    45

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    45

     

    Share-based compensation

    expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    20

     

    ‐

     

    20

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

     

    Other (income) expenses

    (8)

     

    22

     

    1

     

    7

     

    105

     

    2

     

    129

     

    Earnings (loss) before finance costs and income taxes

    149

     

    157

     

    301

     

    9

     

    (246)

     

    27

     

    397

     

    Depreciation and amortization

    191

     

    134

     

    170

     

    77

     

    18

     

    ‐

     

    590

     

    EBITDA

    340

     

    291

     

    471

     

    86

     

    (228)

     

    27

     

    987

     

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    47

     

    ‐

     

    47

     

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    20

     

    ‐

     

    20

     

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

     

    ARO/ERL related expense for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1)

     

    ‐

     

    (1)

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

     

    Adjusted EBITDA

    340

     

    291

     

    471

     

    86

     

    (160)

     

    27

     

    1,055

     
       
       

     

     

    Three Months Ended December 31, 2023

     

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

    (millions of US dollars)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

     

    Sales

    – third party

    3,504

     

    734

     

    895

     

    531

     

    ‐

     

    ‐

     

    5,664

     

     

    – intersegment

    (2)

     

    129

     

    223

     

    84

     

    ‐

     

    (434)

     

    ‐

     

    Sales

    – total

    3,502

     

    863

     

    1,118

     

    615

     

    ‐

     

    (434)

     

    5,664

     

    Freight, transportation and

    distribution

    ‐

     

    87

     

    162

     

    82

     

    ‐

     

    (71)

     

    260

     

    Net sales

    3,502

     

    776

     

    956

     

    533

     

    ‐

     

    (363)

     

    5,404

     

    Cost of goods sold

    2,513

     

    349

     

    671

     

    463

     

    ‐

     

    (360)

     

    3,636

     

    Gross margin

    989

     

    427

     

    285

     

    70

     

    ‐

     

    (3)

     

    1,768

     

    Selling expenses (recovery)

    841

     

    3

     

    4

     

    1

     

    7

     

    (7)

     

    849

     

    General and administrative expenses

    55

     

    3

     

    10

     

    1

     

    104

     

    ‐

     

    173

     

    Provincial mining taxes

    ‐

     

    79

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    79

     

    Share-based compensation recovery

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (7)

     

    ‐

     

    (7)

     

    Impairment of assets

    ‐

     

    ‐

     

    76

     

    ‐

     

    ‐

     

    ‐

     

    76

     

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (14)

     

    ‐

     

    (14)

     

    Other expenses (income)

    77

     

    (3)

     

    26

     

    19

     

    175

     

    25

     

    319

     

    Earnings (loss) before finance costs and income taxes

    16

     

    345

     

    169

     

    49

     

    (265)

     

    (21)

     

    293

     

    Depreciation and amortization

    201

     

    118

     

    146

     

    81

     

    19

     

    ‐

     

    565

     

    EBITDA

    217

     

    463

     

    315

     

    130

     

    (246)

     

    (21)

     

    858

     

    Restructuring costs

    12

     

    ‐

     

    ‐

     

    ‐

     

    8

     

    ‐

     

    20

     

    Share-based compensation recovery

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (7)

     

    ‐

     

    (7)

     

    Impairment of assets

    ‐

     

    ‐

     

    76

     

    ‐

     

    ‐

     

    ‐

     

    76

     

    ARO/ERL related expense for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    142

     

    ‐

     

    142

     

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (14)

     

    ‐

     

    (14)

     

    Adjusted EBITDA

    229

     

    463

     

    391

     

    130

     

    (117)

     

    (21)

     

    1,075

     
       
       

     

     

    Twelve Months Ended December 31, 2024

     

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

    (millions of US dollars)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

     

    Sales

    – third party

    17,832

     

    3,008

     

    3,500

     

    1,610

     

    22

     

    ‐

     

    25,972

     

     

    – intersegment

    ‐

     

    370

     

    807

     

    278

     

    ‐

     

    (1,455)

     

    ‐

     

    Sales

    – total

    17,832

     

    3,378

     

    4,307

     

    1,888

     

    22

     

    (1,455)

     

    25,972

     

    Freight, transportation and distribution

    ‐

     

    389

     

    562

     

    231

     

    ‐

     

    (226)

     

    956

     

    Net sales

    17,832

     

    2,989

     

    3,745

     

    1,657

     

    22

     

    (1,229)

     

    25,016

     

    Cost of goods sold

    13,211

     

    1,448

     

    2,535

     

    1,510

     

    9

     

    (1,227)

     

    17,486

     

    Gross margin

    4,621

     

    1,541

     

    1,210

     

    147

     

    13

     

    (2)

     

    7,530

     

    Selling expenses (recovery)

    3,418

     

    10

     

    26

     

    6

     

    ‐

     

    (25)

     

    3,435

     

    General and administrative expenses

    191

     

    12

     

    24

     

    14

     

    403

     

    ‐

     

    644

     

    Provincial mining taxes

    ‐

     

    255

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    255

     

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    37

     

    ‐

     

    37

     

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    360

     

    ‐

     

    360

     

    Other expenses (income)

    87

     

    25

     

    (135)

     

    33

     

    379

     

    24

     

    413

     

    Earnings (loss) before finance costs and income taxes

    590

     

    1,239

     

    1,100

     

    94

     

    (1,166)

     

    (1)

     

    1,856

     

    Depreciation and amortization

    771

     

    609

     

    589

     

    290

     

    80

     

    ‐

     

    2,339

     

    EBITDA

    1,361

     

    1,848

     

    1,689

     

    384

     

    (1,086)

     

    (1)

     

    4,195

     

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    47

     

    ‐

     

    47

     

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    37

     

    ‐

     

    37

     

    Impairment of assets

    335

     

    ‐

     

    195

     

    ‐

     

    ‐

     

    ‐

     

    530

     

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    35

     

    ‐

     

    35

     

    ARO/ERL related expense for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    151

     

    ‐

     

    151

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    360

     

    ‐

     

    360

     

    Adjusted EBITDA

    1,696

     

    1,848

     

    1,884

     

    384

     

    (456)

     

    (1)

     

    5,355

     
       
       

     

     

    Twelve Months Ended December 31, 2023

     

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

    (millions of US dollars)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

     

    Sales

    – third party

    19,542

     

    3,735

     

    3,804

     

    1,975

     

    ‐

     

    ‐

     

    29,056

     

     

    – intersegment

    ‐

     

    431

     

    931

     

    288

     

    ‐

     

    (1,650)

     

    ‐

     

    Sales

    – total

    19,542

     

    4,166

     

    4,735

     

    2,263

     

    ‐

     

    (1,650)

     

    29,056

     

    Freight, transportation and

    distribution

    ‐

     

    407

     

    528

     

    270

     

    ‐

     

    (231)

     

    974

     

    Net sales

    19,542

     

    3,759

     

    4,207

     

    1,993

     

    ‐

     

    (1,419)

     

    28,082

     

    Cost of goods sold

    15,112

     

    1,396

     

    2,828

     

    1,760

     

    ‐

     

    (1,488)

     

    19,608

     

    Gross margin

    4,430

     

    2,363

     

    1,379

     

    233

     

    ‐

     

    69

     

    8,474

     

    Selling expenses (recovery)

    3,375

     

    12

     

    27

     

    6

     

    ‐

     

    (23)

     

    3,397

     

    General and administrative expenses

    217

     

    13

     

    21

     

    11

     

    364

     

    ‐

     

    626

     

    Provincial mining taxes

    ‐

     

    398

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    398

     

    Share-based compensation recovery

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (14)

     

    ‐

     

    (14)

     

    Impairment of assets

    465

     

    ‐

     

    76

     

    233

     

    ‐

     

    ‐

     

    774

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    91

     

    ‐

     

    91

     

    Other expenses (income)

    158

     

    (1)

     

    (27)

     

    40

     

    257

     

    30

     

    457

     

    Earnings (loss) before finance costs and income taxes

    215

     

    1,941

     

    1,282

     

    (57)

     

    (698)

     

    62

     

    2,745

     

    Depreciation and amortization

    759

     

    463

     

    572

     

    294

     

    81

     

    ‐

     

    2,169

     

    EBITDA

    974

     

    2,404

     

    1,854

     

    237

     

    (617)

     

    62

     

    4,914

     

    Restructuring costs

    20

     

    ‐

     

    ‐

     

    ‐

     

    29

     

    ‐

     

    49

     

    Share-based compensation recovery

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (14)

     

    ‐

     

    (14)

     

    Impairment of assets

    465

     

    ‐

     

    76

     

    233

     

    ‐

     

    ‐

     

    774

     

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    92

     

    ‐

     

    92

     

    ARO/ERL related expense for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    152

     

    ‐

     

    152

     

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    91

     

    ‐

     

    91

     

    Adjusted EBITDA

    1,459

     

    2,404

     

    1,930

     

    470

     

    (267)

     

    62

     

    6,058

     
       
     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars)

    2024

     

     

    2023

     

    2024

     

     

    2023

    Retail sales by product line

     

     

     

     

     

     

     

     

     

    Crop nutrients

    1,528

     

     

    1,808

     

    7,211

     

     

    8,379

    Crop protection products

    948

     

     

    960

     

    6,313

     

     

    6,750

    Seed

    184

     

     

    202

     

    2,235

     

     

    2,295

    Services and other

    228

     

     

    236

     

    918

     

     

    927

    Merchandise

    230

     

     

    251

     

    897

     

     

    1,001

    Nutrien Financial

    77

     

     

    70

     

    361

     

     

    322

    Nutrien Financial elimination 1

    (16)

     

     

    (25)

     

    (103)

     

     

    (132)

     

    3,179

     

     

    3,502

     

    17,832

     

     

    19,542

    Potash sales by geography

     

     

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

     

     

    North America

    245

     

     

    459

     

    1,719

     

     

    2,090

    Offshore 2

    342

     

     

    404

     

    1,658

     

     

    2,076

    Other potash and purchased products

    ‐

     

     

    ‐

     

    1

     

     

    ‐

     

    587

     

     

    863

     

    3,378

     

     

    4,166

    Nitrogen sales by product line

     

     

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

     

     

    Ammonia

    376

     

     

    339

     

    1,232

     

     

    1,337

    Urea and ESN®

    395

     

     

    346

     

    1,480

     

     

    1,624

    Solutions, nitrates and sulfates

    339

     

     

    345

     

    1,300

     

     

    1,367

    Other nitrogen and purchased products

    66

     

     

    88

     

    295

     

     

    407

     

    1,176

     

     

    1,118

     

    4,307

     

     

    4,735

    Phosphate sales by product line

     

     

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

     

     

    Fertilizer

    309

     

     

    378

     

    1,237

     

     

    1,264

    Industrial and feed

    157

     

     

    168

     

    627

     

     

    703

    Other phosphate and purchased products

    5

     

     

    69

     

    24

     

     

    296

     

    471

     

     

    615

     

    1,888

     

     

    2,263

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    2 Relates to Canpotex Limited ("Canpotex") (see Note 10) and includes provisional pricing adjustments for the three months ended December 31, 2024 of $(3) million (2023 – $(40) million) and the twelve months ended December 31, 2024 of $4 million (2023 – $(394) million).

    Note 3 Impairment of assets

    We recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

     

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars)

     

    2024

     

     

    2023

     

    2024

     

     

    2023

    Segment

    Category

     

     

     

     

     

     

     

     

     

    Retail

    Intangible assets

    ‐

     

     

    ‐

     

    200

     

     

    43

     

    Property, plant and equipment

    ‐

     

     

    ‐

     

    120

     

     

    ‐

     

    Other

    ‐

     

     

    ‐

     

    15

     

     

    ‐

     

    Goodwill

    ‐

     

     

    ‐

     

    ‐

     

     

    422

    Nitrogen

    Property, plant and equipment

    ‐

     

     

    76

     

    195

     

     

    76

    Phosphate

    Property, plant and equipment

    ‐

     

     

    ‐

     

    ‐

     

     

    233

    Impairment of assets

    ‐

     

     

    76

     

    530

     

     

    774

         

    Retail – Brazil

    During the three months ended June 30, 2024, due to the ongoing market instability and more moderate margin expectations, we lowered our forecasted EBITDA for the Retail – Brazil cash generating unit ("CGU"). This triggered an impairment analysis.

    We used the fair value less cost to dispose ("FVLCD") methodology (Level 3) based on a market approach using the sales comparison method to assess the recoverable value of the Retail – Brazil CGU at June 30, 2024. This is a change from the methodology used in our 2023 analysis, as the market approach resulted in a more representative fair value of the CGU as restructuring initiatives in Brazil are currently being developed. In 2023, we used the FVLCD methodology based on after-tax discounted cash flows (10-year projections plus a terminal value) and an after-tax discount rate (14.4 percent). In 2024, we incorporated assumptions that an independent market participant would apply.

       

     

     

    Retail – Brazil

     

    (millions of US dollars)

     

    June 30, 2024

     

    Recoverable amount comprised of:

     

     

     

    Working capital and other

     

    324

     

    Property, plant and equipment

     

    92

     

    Intangible assets

     

    ‐

     
       

    The key assumptions with the greatest influence on the calculation of the impairment are the estimated recoverable value of property, plant and equipment and intangible assets. Any change to these estimates could directly impact the impairment amount.

    Nitrogen

    During the three months ended June 30, 2024, we decided that we are no longer pursuing our Geismar Clean Ammonia project. As a result, we recorded an impairment loss of $195 million to fully write off the amount of property, plant and equipment related to this project. As the project was cancelled before it generated revenue, the recoverable amount, which was based on its value in use was $nil.

    Goodwill Impairment Testing

     

    As at December 31 (millions of US dollars)

    2024

     

     

    2023

    Goodwill by CGU or Group of CGUs

     

     

     

     

    Retail – North America

    6,961

     

     

    6,981

    Retail – Australia

    539

     

     

    590

    Potash

    154

     

     

    154

    Nitrogen

    4,389

     

     

    4,389

     

    12,043

     

     

    12,114

     

     

     

     

     

    During the three and twelve months ended December 31, 2024, we performed our annual impairment test on goodwill and did not identify any impairment.

    In testing for impairment of goodwill, we calculate the recoverable amount for a CGU or groups of CGUs containing goodwill. We used the FVLCD methodology based on after-tax discounted cash flows (five-year projections plus a terminal value) and incorporated assumptions an independent market participant would apply. We adjusted discount rates for each CGU or group of CGUs for the risk associated with achieving our forecasts and for the country risk premium in which we expect to generate cash flows. FVLCD is a Level 3 measurement. We use our market capitalization (where applicable) and comparative market multiples to ensure discounted cash flow results are reasonable.

    The key assumptions with the greatest influence on the calculation of the recoverable amounts are the discount rates, terminal growth rates and forecasted EBITDA. The key forecast assumptions were based on historical data and our estimates of future results from internal sources considering industry and market information.

    During our performance of our annual impairment test, the Retail – North America group of CGUs recoverable amount exceeded its carrying amount by $2.8 billion. Goodwill is more susceptible to impairment risk if there is an increase in the discount rate or a deterioration in business operating results or economic conditions and actual results do not meet our forecasts. A reduction in the terminal growth rate, an increase in the discount rate or a decrease in forecasted EBITDA could cause impairment in the future as shown in the table below.

     

     

     

    Key Assumption

     

    Change Required for Carrying Amount

     

    2024 Annual Impairment Testing

     

    Used in Impairment Model

     

    to Equal Recoverable Amount

     

    Terminal growth rate (%)

     

    2.5

     

    1.4

     

    Percentage point decrease

     

    Discount rate 1 (%)

     

    7.3

     

    1.1

     

    Percentage point increase

     

    Forecasted EBITDA over forecast period ($ millions)

     

    8,300

     

    11.1

     

    Percent decrease

     

    1 The discount rate used in the previous measurement at October 1, 2023 was 8.6 percent. At December 31, 2024, the discount rate was 8.0 percent.

     

    The following table indicates the key assumptions used in testing the remaining groups of CGUs:

     

     

    Terminal Growth Rate (%)

     

    Discount Rate (%)

     

    2024

     

     

    2023

     

    2024

     

     

    2023

    Retail – Australia

    2.6

     

     

    2.1

     

    7.9

     

     

    9.0

    Potash

    2.5

     

     

    2.5

     

    6.3

     

     

    7.6

    Nitrogen

    2.3

     

     

    2.3

     

    7.6

     

     

    8.3

    Note 4 Other expenses (income)

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars)

    2024

     

     

    2023

     

    2024

     

     

    2023

    Restructuring costs

    47

     

     

    20

     

    47

     

     

    49

    Earnings of equity-accounted investees

    (23)

     

     

    (1)

     

    (130)

     

     

    (101)

    Bad debt expense

    23

     

     

    4

     

    117

     

     

    55

    Project feasibility costs

    26

     

     

    39

     

    92

     

     

    92

    Customer prepayment costs

    12

     

     

    12

     

    58

     

     

    55

    Legal expenses

    15

     

     

    16

     

    47

     

     

    34

    Consulting expenses

    3

     

     

    3

     

    10

     

     

    21

    Insurance recoveries

    (3)

     

     

    ‐

     

    (65)

     

     

    ‐

    Loss on natural gas derivatives not designated as hedge

    1

     

     

    ‐

     

    8

     

     

    ‐

    Loss related to financial instruments in Argentina

    1

     

     

    ‐

     

    35

     

     

    92

    ARO/ERL related (income) expenses for non-operating sites 1

    (1)

     

     

    142

     

    151

     

     

    152

    Gain on amendments to other post-retirement pension plans

    ‐

     

     

    ‐

     

    ‐

     

     

    (80)

    Other expenses

    28

     

     

    84

     

    43

     

     

    88

     

    129

     

     

    319

     

    413

     

     

    457

    1 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

     

    Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. We utilize various financial instruments such as Blue Chip Swaps or Bonds for the Reconstruction of a Free Argentina ("BOPREAL") that effectively allow companies to transact in US dollars. We incurred losses on these transactions due to the significant divergence between the market exchange rate used for these financial instruments and the official Central Bank of Argentina rate. These losses are recorded as part of loss related to financial instruments in Argentina.

    Note 5 Income taxes

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

     

    2023

     

    2024

     

     

    2023

    Actual effective tax rate on earnings (%)

    33

     

     

    39

     

    40

     

     

    33

    Actual effective tax rate including discrete items (%)

    42

     

     

    (120)

     

    38

     

     

    34

    Discrete tax adjustments that impacted the tax rate

    18

     

    (127)

     

    (13)

     

    28

    Note 6 Financial instruments

    Foreign Currency Derivatives

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars)

    2024

     

     

    2023

     

    2024

     

     

    2023

    Foreign exchange (gain) loss

    (13)

     

     

    (22)

     

    14

     

     

    (10)

    Hyperinflationary loss

    12

     

     

    36

     

    97

     

     

    114

    Loss (gain) on foreign currency derivatives at fair value through profit or loss

    2

     

     

    (28)

     

    249

     

     

    (13)

    Foreign exchange loss (gain), net of related derivatives

    1

     

     

    (14)

     

    360

     

     

    91

     

    For the twelve months ended December 31, 2024, the losses on our foreign currency derivatives were primarily related to Brazil which matured in July 2024. As of December 31, 2024, outstanding derivative contracts were related to our ongoing risk management strategy. The fair value of our net foreign exchange currency derivative (liabilities) assets as at December 31, 2024 was $(13) million (December 31, 2023 – $11 million).

    Natural Gas Derivatives

    In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our 2023 annual consolidated financial statements, respectively. For derivatives that do not qualify as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

    We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge's inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

    Hedging Transaction

     

    Measurement of Ineffectiveness

     

    Potential Sources of Ineffectiveness

    New York Mercantile Exchange ("NYMEX") natural gas hedges

     

    Assessed on a prospective and retrospective basis using regression analyses

     

    Changes in:

    • timing of forecast transactions

    • volume delivered

    • our credit risk or the credit risk of a counterparty

    The fair value of our natural gas derivative assets (liabilities) as at December 31, 2024 was $1 million (December 31, 2023 - $(5) million).

    Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,918 million and fair value of $9,317 million as at December 31, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

    Note 7 Short-term debt

    In 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the "repurchase facility"), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at December 31, 2024, there were no borrowings outstanding under this facility.

    In 2024, we extended the term of our unsecured revolving term credit facility to September 3, 2025 and reduced the facility limit from $1,500 million to $750 million. We also extended the maturity of our $4,500 million unsecured revolving term facility to September 4, 2029.

    Note 8 Long-term debt

       

    (millions of US dollars, except as otherwise noted)

    Rate of interest (%)

     

    Maturity

     

    Amount

     

    Senior notes repaid in 2024

    5.9

     

    November 7, 2024

     

    500

     

     

     

     

     

     

     

     

    Senior notes issued in 2024

    5.2

     

    June 21, 2027

     

    400

     

    Senior notes issued in 2024

    5.4

     

    June 21, 2034

     

    600

     

     

     

     

     

     

    1,000

     
       

    The notes issued in the twelve months ended December 31, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

    In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

    Note 9 Share capital

    Share Repurchase Programs

    The following table summarizes our share repurchase activities during the periods indicated below:

     

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    (millions of US dollars, except as otherwise noted)

    2024

     

     

    2023

     

    2024

     

     

    2023

    Number of common shares repurchased for cancellation

    2,905,718

     

     

    ‐

     

    3,944,903

     

     

    13,378,189

    Average price per share (US dollars)

    47.02

     

     

    ‐

     

    47.31

     

     

    74.73

    Total cost, inclusive of tax

    139

     

     

    ‐

     

    190

     

     

    1,000

     

    As of February 18, 2025, an additional 1,887,537 common shares were repurchased for cancellation at a cost of $96 million and an average price per share of $50.82.

    On February 19, 2025, our Board of Directors approved a share repurchase program for up to five percent of our outstanding common shares. The 2025 normal course issuer bid, which is subject to the acceptance by the Toronto Stock Exchange, will expire after a one-year period, if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

    Dividends Declared

    We declared a dividend per share of $0.54 (2023 – $0.53) during the three months ended December 31, 2024, payable on January 17, 2025 to shareholders of record on December 31, 2024.

    On February 19, 2025, our Board of Directors declared and increased our quarterly dividend to $0.545 per share payable on April 10, 2025, to shareholders of record on March 31, 2025. The total estimated dividend to be paid is $265 million.

    Note 10 Related party transactions

    We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended December 31, 2024 were $34 million (2023 – $32 million) and the twelve months ended December 31, 2024 were $146 million (2023 – $92 million).

     

    As at (millions of US dollars)

    December 31, 2024

     

     

    December 31, 2023

    Receivables from Canpotex

    122

     

     

    162

    Payables to Canpotex

    66

     

     

    64

    Note 11 Accounting policies, estimates and judgments

    IFRS 18, "Presentation and Disclosure in Financial Statements" ("IFRS 18"), which was issued on April 9, 2024, would supersede IAS 1, "Presentation of Financial Statements" and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

    Amendments for IFRS 9 and IFRS 7, "Amendments to the Classification and Measurement of Financial Instruments", which was issued on May 30, 2024, will address diversity in practice by making the requirements more understandable and consistently applied. These amendments will be effective January 1, 2026, and will not apply to comparative information. We are reviewing the standard to determine the potential impact.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250211173070/en/

    Jeff Holzman

    Vice President, Investor Relations

    (306) 933-8545

    [email protected]

    Get the next $NTR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    7/11/2025$66.00Buy → Hold
    Jefferies
    6/17/2025$68.00Outperform → Mkt Perform
    Raymond James
    5/14/2025$62.00Sector Outperform → Sector Perform
    Scotiabank
    3/13/2025$53.00Sell
    Goldman
    1/21/2025$55.00 → $56.00Overweight → Equal Weight
    Barclays
    1/13/2025$50.00 → $58.00Underweight → Overweight
    Piper Sandler
    1/13/2025$40.00 → $50.00Underweight → Neutral
    Analyst
    12/3/2024$58.00 → $60.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2024 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 8, 2024 (the "Meeting"). A total of 369,251,444 common shares, representing 74.66% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.33% 1.67% Maura J. Clark 98.95% 1.05% Russell K. Girling 98.31% 1.69% Michael J. Hennigan 94.88% 5.12% Miranda C. Hubbs 98.48% 1.52%

    5/8/24 7:11:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2023 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 10, 2023 (the "Meeting"). A total of 386,934,221 common shares, representing 77.42% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 95.86% 4.14% Maura J. Clark 95.57% 4.43% Russell K. Girling 93.30% 6.70% Michael J. Hennigan 91.15% 8.85% Miranda C. Hubbs 95.80% 4.20

    5/10/23 7:44:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on September 29, 2025. Registered sharehold

    8/6/25 5:30:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Second Quarter 2025 Results

    First half results supported by strong operational performance and favorable fertilizer market fundamentals. Increasing 2025 full-year Potash sales volume guidance range, maintaining capital allocation priorities and continuing to show progress on 2026 performance targets. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its second quarter 2025 results, with net earnings of $1.2 billion ($2.50 diluted net earnings per share). Second quarter 2025 adjusted EBITDA1 was $2.5 billion and adjusted net earnings per share1 was $2.65. "Nutrien delivered growth in earnings and cash flow in the first half of 2025, demonstrating strong

    8/6/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Second Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release second quarter 2025 results after market close on Wednesday, August 6. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EDT on Thursday, August 7. Investors can access the call by dialing 1-800-206-4400 or 1-289-514-5005. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider of crop inputs and services. We o

    7/9/25 5:03:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    SEC Filings

    View All

    SEC Form SD filed by Nutrien Ltd.

    SD - Nutrien Ltd. (0001725964) (Filer)

    8/7/25 4:18:01 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 11-K filed by Nutrien Ltd.

    11-K - Nutrien Ltd. (0001725964) (Filer)

    6/23/25 5:23:28 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 11-K filed by Nutrien Ltd.

    11-K - Nutrien Ltd. (0001725964) (Filer)

    6/23/25 5:22:27 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien downgraded by Jefferies with a new price target

    Jefferies downgraded Nutrien from Buy to Hold and set a new price target of $66.00

    7/11/25 8:11:56 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by Raymond James with a new price target

    Raymond James downgraded Nutrien from Outperform to Mkt Perform and set a new price target of $68.00

    6/17/25 7:48:03 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by Scotiabank with a new price target

    Scotiabank downgraded Nutrien from Sector Outperform to Sector Perform and set a new price target of $62.00

    5/14/25 8:57:32 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Financials

    Live finance-specific insights

    View All

    Nutrien Declares Quarterly Dividend of US$0.545 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on September 29, 2025. Registered sharehold

    8/6/25 5:30:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports Second Quarter 2025 Results

    First half results supported by strong operational performance and favorable fertilizer market fundamentals. Increasing 2025 full-year Potash sales volume guidance range, maintaining capital allocation priorities and continuing to show progress on 2026 performance targets. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its second quarter 2025 results, with net earnings of $1.2 billion ($2.50 diluted net earnings per share). Second quarter 2025 adjusted EBITDA1 was $2.5 billion and adjusted net earnings per share1 was $2.65. "Nutrien delivered growth in earnings and cash flow in the first half of 2025, demonstrating strong

    8/6/25 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Second Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release second quarter 2025 results after market close on Wednesday, August 6. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EDT on Thursday, August 7. Investors can access the call by dialing 1-800-206-4400 or 1-289-514-5005. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider of crop inputs and services. We o

    7/9/25 5:03:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials